Announce Date | 07/30/2025 |
EPS Normalized Actual | $5.94 (Beat by $2.69) |
EPS GAAP Actual | $5.94 (Beat by $2.69) |
Revenue Actual | $16.633B |
Revenue Surprise | Beat by $16633M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $4.36017 |
EPS GAAP Estimate | $4.36017 |
Revenue Estimate | $15.652441571B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0 | -3.1694 | 16.633B | 5.53% | 1475.48M |
FQ1 2025 (Mar 2025) | 0 | -2.52183 | 16.452B | 7.25% | 2399.9M |
FQ4 2024 (Dec 2024) | 0 | 0 | 16.506B | 10.14% | 16506M |
FQ3 2024 (Sep 2024) | 4.39 | 4.39 | 16.627B | 20.56% | 16627M |
FQ2 2024 (Jun 2024) | 0 | 0 | 15.714B | 11.04% | 15714M |
FQ1 2024 (Mar 2024) | 0 | 0 | 15.259B | 19.15% | 15259M |
FQ4 2023 (Dec 2023) | 0 | 0 | 14.832B | 100% | 14832M |
FQ3 2023 (Sep 2023) | -0.16 | -0.16 | 13.208B | 100% | 13208M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
4.36017
Consensus Revenue Estimates
15.652441571B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 8.21243 | -- | 8.21243 | 8.21243 | 1 |
FQ3 2027 (Sep 2027) | 5.30847 | -- | 5.30847 | 5.30847 | 1 |
FQ2 2027 (Jun 2027) | 3.15583 | -- | 3.15583 | 3.15583 | 1 |
FQ1 2027 (Mar 2027) | 6.60115 | -- | 6.60115 | 6.60115 | 1 |
FQ4 2026 (Dec 2026) | 7.64475 | -- | 7.64475 | 7.64475 | 1 |
FQ3 2026 (Sep 2026) | 4.66429 | -- | 4.66429 | 4.66429 | 1 |
FQ2 2026 (Jun 2026) | 3.23726 | -- | 3.23726 | 3.23726 | 1 |
FQ1 2026 (Mar 2026) | 6.52793 | -- | 6.52793 | 6.52793 | 1 |
FQ4 2025 (Dec 2025) | 7.22841 | -- | 7.22841 | 7.22841 | 1 |
FQ3 2025 (Sep 2025) | 4.36017 | -0.68 | 4.36017 | 4.36017 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 17.23B | -- | 17.23B | 17.23B | 1 |
FQ3 2027 (Sep 2027) | 18.59B | -- | 18.59B | 18.59B | 1 |
FQ2 2027 (Jun 2027) | 17.94B | -- | 17.94B | 17.94B | 1 |
FQ1 2027 (Mar 2027) | 16.51B | -- | 16.51B | 16.51B | 1 |
FQ4 2026 (Dec 2026) | 15.81B | -- | 15.81B | 15.81B | 1 |
FQ3 2026 (Sep 2026) | 17.19B | -- | 17.19B | 17.19B | 1 |
FQ2 2026 (Jun 2026) | 16.64B | 0.03 | 16.64B | 16.64B | 1 |
FQ1 2026 (Mar 2026) | 15.22B | -8.1 | 15.22B | 15.22B | 1 |
FQ4 2025 (Dec 2025) | 14.77B | -11.76 | 14.77B | 14.77B | 1 |
FQ3 2025 (Sep 2025) | 15.65B | -6.23 | 15.65B | 15.65B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
3
EPS # of in-lines
4
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 3.1694 | 0 | -3.1694 | -INF% |
FQ1 2025 (Mar 2025) | 2.52183 | 0 | -2.52183 | -INF% |
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | 4.39 | 4.39 | 100% | |
FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | -0.16 | -0.16 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $15.16B | $16.63B | $1475.48M | 8.87% |
FQ1 2025 (Mar 2025) | $14.05B | $16.45B | $2399.9M | 14.59% |
FQ4 2024 (Dec 2024) | $0B | $16.51B | $16506M | 100% |
FQ3 2024 (Sep 2024) | $0B | $16.63B | $16627M | 100% |
FQ2 2024 (Jun 2024) | $0B | $15.71B | $15714M | 100% |
FQ1 2024 (Mar 2024) | $0B | $15.26B | $15259M | 100% |
FQ4 2023 (Dec 2023) | $0B | $14.83B | $14832M | 100% |
FQ3 2023 (Sep 2023) | $0B | $13.21B | $13208M | 100% |